Dr. Matthew E. Wells, MD

Dr. Wells practices at Andrews Institute Asc - HOPD in Gulf Breeze, Florida.

Dr. Wells' NPI, 1639160955, was assigned on November 4, 2005. Dr. Wells graduated from Rutgers Robert Wood Johnson Medical School in 1999. Dr. Wells holds Florida license ME0094642.

Dr. Wells' primary practice is Andrews Institute Asc - HOPD, at 1040 Gulf Breeze Pkwy, Gulf Breeze, FL 32561.

Dr. Wells' primary practice is Andrews Institute Asc - HOPD in Gulf Breeze, Florida. Dr. Wells is also affiliated with Holy Cross Health. The medical group on file is Ortho Florida. Dmand AI also links Dr. Wells to 2 more hospitals, 2 group practices and clinics, 2 medical groups, 1 home health agency and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wells practices, 8 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Wells' primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Wells is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Wells' licenses on file in 2 states: Florida and Alabama.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, carpal tunnel syndrome, enthesopathy in arms, fluid in a joint and hand joint or tendon inflammation among the conditions Dr. Wells treats.

CMS data shows 3,719 Medicare services from Dr. Wells across 26 procedure codes in 2024, for 298 Medicare patients. Medicare paid $106,560 for them. Every service was in an office.

CMS counts 298 Medicare patients who saw Dr. Wells in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have arthritis, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wells' median patient age at 67, with 48% women.

In 2024, Dr. Wells wrote 201 Medicare Part D claims for 115 patients. 100% of them were for generic drugs. CMS names the drug for 176 of them, across 6 drugs with 11 or more claims each, at $921 in total drug cost. In 2023, CMS named 208 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Wells for performance year 2024, reported individually. Dr. Wells accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Wells, more than 48% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Wells to 1 clinical trial. Conditions studied include Axial Spondyloarthritis and Ankylosis. Open Payments lists research payments to Dr. Wells that name 1 trial.

CMS Open Payments shows 82 general payments to Dr. Wells from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Anika Therapeutics, Inc. paid the most, $1,317. It also lists 1 research payment totaling $858 in 2016, naming 1 clinical trial.

Dr. Wells graduated from Rutgers Robert Wood Johnson Medical School in 1999. Dr. Wells is a member of AAOS and AOSSM.

Dr. Wells is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.